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Liquid and Gel Platelet Rich Plasma as Skin Healing Adjuvant 
Plasma Rico em Plaquetas em suas frações líquida e em gel como adjuvantes da cicatrização cutânea
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Paula Barros Terraciano2, Viviam Pignone1, Marta Justina Cioato3,  
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ABSTRACT
Background: In recent decades, many researches have been conducted on processes involved in tissue repairing, mainly in 
the development of resources and technology designed to improve the wound healing progress. Platelet rich plasma (PRP) 
derived from autologous blood is defined as a plasma volume with platelet concentration higher than physiological level. It 
is an autogenous and low cost source of growth factors, which are essential for tissue regeneration due to their angiogenic, 
mitogenic, and chemotactic properties. The aim of this study was evaluate two forms of PRP- liquid and gel - regarding their 
capacity to influence quality and repair time of standardized skin injuries. 
Materials, Methods & Results: New Zealand healthy rabbits were distributed in three groups (n = 6): control group (CG), 
liquid platelet rich plasma group (LIQPRP), and gel platelet rich plasma group (GELPRP). Acute skin lesions were inducted 
in two areas approximately 2 cm close to scapular edge and depth including epidermis, dermis, and hypodermis to external 
muscular fascia. Animals received treatment according to each group. Injuries were measured with digital pachymeter in 
two directions: longer length (l) and longer width (w), every two days. Areas and healing rates were calculated. Microscopic 
analysis samples were collected on days seven and 14 and evaluated through hematoxylin and eosin staining (HE) for global 
tissue examination, and through Masson’s trichrome (MT) to collagen fibers present within the interstice. These analyzes con-
sidered: angiogenesis, inflammation infiltrated and collagen fibers quantity. Immunohistochemistry with anti-Ki-67 antibody 
was utilized for proliferative profile assessment. Kruskal-Wallis’ non-parametric tests of independent samples was performed 
for comparison of values obtained through platelet count, referring to evaluation of platelet increase on treatments. Scar 
contraction rate (CR) was evaluated through Shapiro-Wilk’s normality test, and then submitted to mixed models test. Results 
obtained by histopathological and immunohistochemistry were also evaluated by Shapiro-Wilk’s normality test (for all tests 
a 5% level of significance was considered). Platelet concentration achieved with liquid PRP was 8.64 and gel PRP reached 
5.62 times higher than physiological values. Platelet increase mean for both groups was 7.95. No statistical significance was 
observed between groups. No side-effects or adverse reactions related to PRP usage were observed while study was conducted.
Discussion: In the present study, there was a need to raise platelet poor plasma volume in order to obtain autogenous thrombin 
required for gel PRP. After this modification, a stable and reasonable platelet concentration gel was produced. However, this 
form of PRP application requires more time for sample preparation, increasing the production cost. Furthermore, injection of 
liquid PRP directly in the wound site activates platelets by generated substances due to needle perforation, and mainly due to 
tissue trauma generated at the lesion site. Relating to the therapies administered, gel PRP was considered more manageable, 
since 3D structure could easily adapt to wound site after simply deposition of it. Liquid PRP was administered with needle 
and syringe, which required the surgeon to be more careful and perform a slow injection in order to avoid any spill and loss 
of material. Furthermore, histopathological analysis did not point any clot traces formed by gel PRP dehydration, although it 
is not possible to ensure that the clot was eliminated, reabsorbed, or even removed by the animal. By this protocol, a stable 
and reasonable platelet concentration gel was produced. Further studies are encouraged as well as employment of alternative 
diagnostic tools, in order to better understand found results.
Keywords: skin, regenerative therapy, cell therapy, growing factors, platelets.
Descritores: pele, terapia regenerativa, terapia celular, fatores de crescimento, plaquetas.
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INTRODUCTION
Platelets (PL) are blood cells that play an 
important role in homeostasis and are also one of the 
main sources of growth factors (GF). Several studies 
have shown that application of autogenous concentrates 
derived from platelet or platelet rich plasma (PRP) 
within a lesion area can accelerate tissue repair. This 
study aims to evaluate PRP usage in two forms: liquid 
and gel, in relation to their ability to influence qual-
ity and repair time of standard skin injuries in New 
Zealand rabbits. 
MATERIALS AND METHODS
This research utilized 18 New Zealand healthy 
female rabbits, aged between four and five months and 
body mass between two and three kilograms, from 
a breeder registered to Unidade de Experimentação 
Animal from Hospital de Clínicas de Porto Alegre 
(UEA-HCPA). 
PRP Centrifugation Protocol
Subsequently to pilot studies [6] a PRP 
preparation protocol was selected for application. 
Venipunction of jugular vein was utilized for blood 
sample collection, due to high volume needed. Thus, 
punction area was prepared with animals anesthetized, 
and 15 mL of blood was collected with a 25x7 needle 
attached to 10 mL syringe filled with 1 mL sodium 
citrate anticoagulant. Blood sample was stored in 
four flasks with 0.5 mL sodium citrate each and was 
immediately sent to Laboratório de Embriologia e 
Diferenciação Celular/HCPA for processing. One mL 
from whole blood sample was saved for platelet and 
other cellular counts. All procedure was conducted in 
laminar flow hood in order to keep an aseptic sample 
since the product would be administered to animals. 
Protocol utilized for PRP obtaining proposes 
two centrifugations (Eppendorf®)1, the first one at 250 g 
for 10 min. After that, sample had three distinct layers: 
lower layer, containing red blood cells, intermediate 
layer, formed by a “cloudy zone”, that included leuko-
cytes and larger platelets, and upper layer, comprised 
by the plasma. Cloudy zone and plasma were collected, 
and the remaining volume was discarded. Collected 
fraction was submitted to a second centrifugation at 
1000 g for 10 min. By the end of this procedure, sample 
showed a pellet and the supernatant that was composed 
by plasma. Pellet was collected along with 150 µL from 
plasma, which would both form PRP product after ho-
mogenization. Product was transferred to a microfuge 
tube and delivered to surgeon for immediate transplant.
Gel PRP was obtained following all steps 
above until the end of second centrifugation. Then, 
pellet was collected along with 2 mL of supernatant. A 
0.5 mL aliquot was destined to platelet count and 1,5 
mL aliquot was divided in two portions and transferred 
to 24-well plates, used as circular templates, and 150 
µL of calcium gluconate was added for coagulation and 
gel formation. Products were sent to surgery center for 
immediate transplantation.
Platelet count was conducted at blood collec-
tion time and by the end of each concentration protocol 
in all samples, by automatic method. Platelet quantity 
reached in each sample and basal values were both 
analyzed.
Surgical Procedure
Animals under general anesthesia had the dor-
sal skin region delimitated in two areas approximately 
2 cm close to scapular edge, about 6 cm apart from 
each other. Delimitated areas had the skin removed 
and injury depth including epidermis, dermis, and 
hypodermis to external muscular fascia.
Therapeutic procedures
Animals were randomly divided in three 
groups (n = 6): control group (CG), liquid platelet rich 
plasma group (LIQPRP), and gel platelet rich plasma 
group (GELPRP). Immediately after injury assessment, 
animals received the treatment according to group they 
composed (Figure 1).
Sample obtaining
After 7 or 14 days period, animals were 
submitted to a new surgery for total lesion area re-
moval, including 2 mm beyond boundary of scar and 
neighboring healthy tissue. Scar from left side was 
removed at day 7 of post-surgery, and right side scar 
was collected at day 14 of post-surgery. Fragments 
were fixed in 10% formaldehyde, embedded in paraf-
fin and processed.
Morphometric evaluation
Injuries were measured with digital pachymeter 
in two directions: longer length (l) and longer width 
(w), on days 0, 2, 4, 6, 7, 8, 10, 12, and 14. These data 
allowed the calculation of lesion area in each evaluation. 
Wound contraction area (C) was determined subtracting 
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initial area (A1) measured at day 0 (injury induction day), 
from lesion measurements obtained in the following 
evaluation days (x = 2, 4, 6, 7, 8, 10, 12, and 14), so 
that C=AX–A1. Scar contraction rate (CR) was assessed 
based on previous results, where CR= C x 100/A1.
Microscopic evaluations
Histological sections were stained by Hema-
toxylin and Eosin (HE) technique, for global evaluation 
of tissue slices, and by Masson’s Trichrome (MT), to 
examine presence of collagen fibers.
In order to compare the different treatments 
we analyzed histological sections as follows: angio-
genesis, shown by granulation tissue, based on newly 
formed vessels and fibroblasts; inflammatory infiltrate, 
by presence and quantity of mononuclear and poly-
morphonuclear cells; and collagen fibers quantity. 
Proliferative profile evaluation was performed by 
immunohistochemistry analysis with anti-Ki-67 anti-
body. Analyzes were evaluated by categorical variable: 
strong, moderate, and weak.
Statistical Analysis
Kruskal-Wallis’ non-parametric tests of inde-
pendent samples were utilized for comparison of values 
obtained through platelet count, referring to evaluation 
of platelet increase on liquid and gel PRP treatments. 
Scar contraction rate (CR) was evaluated through 
Shapiro-Wilk’s normality test, and then submitted to 
mixed models test. Obtained results by histopathology 
and immunohistochemistry analysis were compared by 
the same test. All tests considered a significance level 
of 5% (P < 0.05).
RESULTS
Platelet count
All animals treated with PRP, regardless of 
the form (liquid or gel), had basal platelet count 
determined for further analysis of platelet increment 
reached through concentration protocol. Platelet 
concentration achieved with liquid PRP was 8.64 
times higher than physiological values (mean of 
basal platelet count from all samples), and gel PRP 
reached 5.62 times more platelet concentration than 
physiological values. Platelet increase mean for both 
groups was 7.95. No statistical significance was ob-
served between groups.
Morphometric evaluation
Measurements at days 0, 2, 4, 6, 7, 8, 10, 12, 
and 14 allowed calculation of lesion area (larger length 
versus larger width) and wound contraction area (C), 
subtracting initial area (A1) determined on day 0 (injury 
induction day), from lesion area obtained on following 
days of evaluation (x = 2, 4, 6, 7, 8, 10, 12, and 14), so 
that C=AX – A1. Scar contraction rate (CR) was evalu-
ated based on previous results, where CR= C x 100/
A1 (Figures 2 & 3).
Histopathological parameters (inflammatory 
reaction, collagen deposition, and angiogenesis) did 
not show difference in group means at days 7 and 14. 
Immunohistochemistry parameters referring to epithelial 
and fibroblast proliferation mean percentages revealed 
significant difference between LIQPRP group and CG 
at day 14 (Figure 4).
Figure 1. Therapeutic procedures executed after skin injury induction in rabbits. (A) Liquid platelet rich plasma injection in 1 mL 
final volume. (B) Gel platelet rich plasma administered on the wound site.
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Figure 2. Average contraction rate (%) increase from each group “versus” 
observation days.  Difference between treatments can be observed until day 
6, whereas by the end of evaluation there are no more differences.
Figure 3. Clinical evaluations. Lesions view on clinical evaluations at 
days 7 and 14 post-surgery. At 14th day all groups exhibited similar rates 
in injury healing.
Figure 4. Immunohistochemistry parameters (epithelial and fibroblastic proliferation). There is sig-
nificant difference between means of LIQPRP group and CG at evaluation day 14.
DISCUSSION
The main concern about employment of a 
product derived from the animal itself was due to pos-
sibility of immunological reaction associated to platelet 
membrane antigens, which could lead to growth factors 
secretion inability, and therefore in a therapeutic effect 
failure. These circumstances were also addressed by 
other studies [8]. Concerning the possibility of clinical 
application, utilization of an autologous product can 
avoid infectious diseases transmission, an important 
point to be considered not only for animals but also 
for human treatments [24].
PRP method utilized in this study was able to 
achieve platelet concentration higher than 1.000.000 
µL-1, increasing, on average, 7.95 times basal values. 
This concentration is higher than previous described 
protocols [1,12,15,26], which could not reach three 
times platelet concentration with patient’s blood. 
Besides, we found higher concentration than those 
obtained by automatic methods, that raised levels one 
to four times physiological levels [11].
 In the present study, there was a need to raise 
platelet poor plasma volume (2 mL collected fraction) 
in order to obtain autogenous thrombin required for gel 
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PRP. After this modification, a stable and reasonable 
platelet concentration gel was produced. However, this 
form of PRP application requires more time for sample 
preparation, since it needs to become a gel, therefore 
increasing the production cost. Furthermore, injection 
of liquid PRP directly in the wound site activates plate-
lets by generated substances due to needle perforation, 
and mainly due to tissue trauma generated at the lesion 
site [25].
Relating to the therapies administered, gel PRP 
was considered more manageable, since 3D structure 
could easily adapt to wound site after simply deposition 
of it. Liquid PRP was administered with needle (0.7 X 
25mm) and syringe (3 mL), which required the surgeon 
to be more careful and perform a slow injection in order 
to avoid any spill and loss of material.
The study did not show any side effects or ad-
verse reactions that could be attributed to PRP usage. 
PRP gel usage demonstrated not to elongate inflam-
matory phase and also not to produce any deleterious 
changes, such as necrotic tissue and foreign body 
reaction stimulus - these were previous concerns since 
gel PRP was a 3D biomaterial transplanted to wound 
site. Furthermore, histopathological analysis did not 
point any clot traces formed by gel PRP dehydration, 
although it is not possible to ensure that the clot was 
eliminated, reabsorbed, or even removed by the animal. 
Literature does not indicate any conclusive information 
regarding what happens to gel PRP fraction after its 
effect within the tissue.
Despite wound contraction rate had shown 
some improvement signals - i.e., elapsed time for heal-
ing - for GELPRP group on initial days of evaluation 
(2, 4, and 6), by the end of the experiment there was no 
difference between mean rates within treated groups. 
At day 14 - last day of experiment - all groups exhibited 
similar rates in injury healing. Indeed, regardless of 
several authors relates that they have found significant 
improvements in tissue healing and bone repairing us-
ing PRP, others did not notice the same benefits [15]. 
Different studies also could not demonstrate gel PRP 
efficiency in the treatment of injuries in experimental 
models [8,14,16]. Variations in some key features of 
PRP including platelet concentration, and coagulation 
activator, can alter PRP quality [2]. Platelet inability 
to secret growth factors, or even early release of them 
can be another reasonable explanation [4,11]. Morpho-
logical analysis of platelets on blood smear is highly 
recommended as a tool to evaluate product quality, 
because platelets have different morphology when 
activated, and display cytoplasmic elongations [15], 
however it can cause a great delay in product deliver. 
Moreover, material could have been submitted to flow 
cytometry [3]. Nevertheless, flow cytometry requires 
specialists, limiting employment of this technique. 
Inability of autogenous thrombin to activate platelets 
is also a possibility that could explain PRP therapeutic 
failure. To address this hypothesis, a study [19] sug-
gested that when autogenous thrombin is being utilized, 
its concentration should be validated by amidolytic as-
say. This approach depends on thrombin quantification, 
therefore specific equipment and materials are needed, 
resulting in higher product cost and addition of steps 
for its achievement [20]. 
There is a hypothesis regarding growth factors 
overload causing dose dependent inhibitory effect. This 
can be questioned since LIQPRP group has reached 
unsatisfying results for contraction rate comparing to 
GELPRP group. LIQPRP group reached a mean of 
8.64, while GELPRP mean value was 5.62 times basal 
values. Some studies analyzed PRP effectiveness in 
increasing tissue repair, relating their results with sev-
eral administered platelet concentrations. Results have 
shown that PRP effectiveness may follow concentration 
dependence pattern, that is, really high concentrations 
might cause prejudicial effect [21], however there is 
still no consensus about what increment levels would 
be ideal and from what value there is no more benefit, 
and more importantly, when the product starts being 
prejudicial for healing process.
CONCLUSIONS
Based on results obtained in this study, PRP 
local administration did not accelerate the healing 
process upon morphometric evaluation 14 days after 
surgery, with the use of liquid PRP demonstrating lower 
epithelialization levels by histopathological evaluation 
compared to the Control group 14 days after surgery.
New studies exploring different diagnostic 
tools are highly recommended in order to better under-
stand the results and provide improvements in current 
treatments.
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